Your browser doesn't support javascript.
loading
Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections.
Monteil, Vanessa; Kwon, Hyesoo; John, Lijo; Salata, Cristiano; Jonsson, Gustav; Vorrink, Sabine U; Appelberg, Sofia; Youhanna, Sonia; Dyczynski, Matheus; Leopoldi, Alexandra; Leeb, Nicole; Volz, Jennifer; Hagelkruys, Astrid; Kellner, Max J; Devignot, Stéphanie; Michlits, Georg; Foong-Sobis, Michelle; Weber, Friedemann; Lauschke, Volker M; Horn, Moritz; Feldmann, Heinz; Elling, Ulrich; Penninger, Josef M; Mirazimi, Ali.
Afiliação
  • Monteil V; Karolinska Institute and Karolinska University Hospital, Department of Laboratory Medicine, Unit of Clinical Microbiology, Stockholm, Sweden.
  • Kwon H; National Veterinary Institute, Uppsala, Sweden.
  • John L; National Veterinary Institute, Uppsala, Sweden.
  • Salata C; Department of Molecular Medicine, University of Padova, Padova, Italy.
  • Jonsson G; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Vorrink SU; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, A-1030, Vienna, Austria.
  • Appelberg S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Youhanna S; Public Health Agency of Sweden, Solna, Sweden.
  • Dyczynski M; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Leopoldi A; Acus Laboratories GmbH, Cologne, Germany.
  • Leeb N; JLP Health GmbH, Vienna, Austria.
  • Volz J; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Hagelkruys A; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Kellner MJ; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Devignot S; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Michlits G; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Foong-Sobis M; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, A-1030, Vienna, Austria.
  • Weber F; Karolinska Institute and Karolinska University Hospital, Department of Laboratory Medicine, Unit of Clinical Microbiology, Stockholm, Sweden.
  • Lauschke VM; Acus Laboratories GmbH, Cologne, Germany.
  • Horn M; JLP Health GmbH, Vienna, Austria.
  • Feldmann H; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria.
  • Elling U; Institute for Virology, FB10-Veterinary Medicine, Justus Liebig University, Giessen, Germany.
  • Penninger JM; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Mirazimi A; University Tübingen, Tübingen, Germany.
Nat Commun ; 14(1): 6785, 2023 10 25.
Article em En | MEDLINE | ID: mdl-37880247
ABSTRACT
Marburg and Ebola filoviruses are two of the deadliest infectious agents and several outbreaks have occurred in the last decades. Although several receptors and co-receptors have been reported for Ebola virus, key host factors remain to be elucidated. In this study, using a haploid cell screening platform, we identify the guanine nucleotide exchange factor CCZ1 as a key host factor in the early stage of filovirus replication. The critical role of CCZ1 for filovirus infections is validated in 3D primary human hepatocyte cultures and human blood-vessel organoids, both critical target sites for Ebola and Marburg virus tropism. Mechanistically, CCZ1 controls early to late endosomal trafficking of these viruses. In addition, we report that CCZ1 has a role in the endosomal trafficking of endocytosis-dependent SARS-CoV-2 infections, but not in infections by Lassa virus, which enters endo-lysosomal trafficking at the late endosome stage. Thus, we have identified an essential host pathway for filovirus infections in cell lines and engineered human target tissues. Inhibition of CCZ1 nearly completely abolishes Marburg and Ebola infections. Thus, targeting CCZ1 could potentially serve as a promising drug target for controlling infections caused by various viruses, such as SARS-CoV-2, Marburg, and Ebola.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Proteínas de Transporte Vesicular / Ebolavirus / Marburgvirus / Doença do Vírus de Marburg Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Proteínas de Transporte Vesicular / Ebolavirus / Marburgvirus / Doença do Vírus de Marburg Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia